![](/img/cover-not-exists.png)
The experimental neuroprotectant leukaemia inhibitory factor (LIF) does not compromise antitumour activity of paclitaxel, cisplatin and carboplatin
Frances M. Boyle, Cecilie Beatson, Robyn Monk, Susan L. Grant, John B. KurekVolume:
48
Language:
english
Pages:
6
DOI:
10.1007/s00280-001-0382-6
Date:
December, 2001
File:
PDF, 145 KB
english, 2001